MALIGNANT TENOSYNOVIAL GIANT CELL TUMOR OF SOFT TISSUE

Clinical trials for MALIGNANT TENOSYNOVIAL GIANT CELL TUMOR OF SOFT TISSUE explained in plain language.

Never miss a new study

Get alerted when new MALIGNANT TENOSYNOVIAL GIANT CELL TUMOR OF SOFT TISSUE trials appear

Sign up with your email to follow new studies for MALIGNANT TENOSYNOVIAL GIANT CELL TUMOR OF SOFT TISSUE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for rare childhood cancer: drug cocktail aims to shrink tumors and prevent return

Disease control Recruiting now

This study is for children and young adults (up to age 30) with a rare type of soft tissue cancer called non-rhabdomyosarcoma. It tests whether adding the drugs pazopanib and selinexor to standard chemotherapy can improve outcomes. Participants receive treatment tailored to their…

Matched conditions: MALIGNANT TENOSYNOVIAL GIANT CELL TUMOR OF SOFT TISSUE

Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control

Last updated Aug 05, 2026 00:00 UTC

MALIGNANT TENOSYNOVIAL GIANT CELL TUMOR OF SOFT TISSUE

Get alerted when new MALIGNANT TENOSYNOVIAL GIANT CELL TUMOR OF SOFT TISSUE trials appear

New hope for rare childhood cancer: drug cocktail aims to shrink tumors and prevent return